According to Retractable Technologies's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -17. At the end of 2022 the company had a P/E ratio of 10.9.
Year | P/E ratio | Change |
---|---|---|
2022 | 10.9 | 160.32% |
2021 | 4.20 | -68.93% |
2020 | 13.5 | -27.91% |
2019 | 18.8 | -287.5% |
2018 | -10.00 | 105.88% |
2017 | -4.86 | -21.66% |
2016 | -6.20 | -142% |
2015 | 14.8 | -132.48% |
2014 | -45.5 | 283.71% |
2013 | -11.8 | 158.71% |
2012 | -4.58 | -107.76% |
2011 | 59.0 | 34.86% |
2010 | 43.8 | -1300.46% |
2009 | -3.64 | 97.23% |
2008 | -1.85 | -57.45% |
2007 | -4.34 | -65.44% |
2006 | -12.6 | -61.5% |
2005 | -32.6 | -1724.72% |
2004 | 2.01 | -92.33% |
2003 | 26.2 | -416.84% |
2002 | -8.26 | -27.29% |
2001 | -11.4 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Becton Dickinson BDX | 44.4 | -361.29% | ๐บ๐ธ USA |
Tandem Diabetes Care
TNDM | -10.9 | -35.71% | ๐บ๐ธ USA |
ICU Medical
ICUI | -50.9 | 199.62% | ๐บ๐ธ USA |
Antares Pharma ATRS | 16.4 | -196.71% | ๐บ๐ธ USA |
Insulet PODD | 98.4 | -678.59% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.